Clinical News

Study Suggests Selenium Shows No Benefit in Prevention of Lung Cancer

06/07/2010 0 Comments Contact Our News Editors

Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer -- either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.

Results from the decade-long study, initiated by the Eastern Cooperative Oncology Group, were presented June 5 at the American Society of Clinical Oncology 2010 Annual Meeting by Daniel D. Karp, M.D., professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center.

News Source:

University of Texas M. D. Anderson Cancer Center (2010, June 5). Selenium shows no benefit in prevention of lung cancer, study suggests. ScienceDaily. Retrieved June 7, 2010, from http://www.sciencedaily.com /releases/2010/06/100605112545.htm

Click here to read the entire article...